Low field combined diffusion-relaxation MRI for mapping placenta structure and function
Combined diffusion-relaxation MRI shows potential for improved characterisation of pregnancy complications. All existing diffusion-relaxation studies in the placenta are at high field strength, mostly 3T. Here we demonstrate quantitative multi-parametric mapping in the placenta with combined T2*-diffusion MRI at low-field strength (0.55T). We present 56 placental MRI scans performed on a commercially available 0.55T scanner. We acquired the images using a combined T2*-diffusion technique that simultaneously acquires multiple diffusion preparations and echo times. We processed the data to produce quantitative T2* and diffusivity maps using a combined T2*-ADC model. We compared the derived quantitative parameters across gestation in healthy controls and a cohort of clinical cases. Quantitative parameter maps show similar spatial patterns, but different absolute values, to previous experiments at high field strength, with similar trends in T2* and ADC against gestational age observed. Combined T2*-diffusion placental MRI is reliably achievable at 0.55T. The advantages of low-field imaging - such as reduced cost, ease of deployment, improved accessibility, greater patient comfort due to the wider bore, and longer T2* values enabling greater absolute range - can support the broader adoption of quantitative placental MRI techniques, such as combined T2*-diffusion, as a complementary tool to ultrasound during pregnancy. • Demonstrate combined T2*-diffusion MRI in the placenta at low field strength (0.55T), using a commercially available scanner. • Present quantitative T2* and ADC maps from 56 scans, showing spatial patterns and gestational trends consistent with high-field studies. • Show repeatability of the technique with a test–retest scan. • Highlight the potential to combine the practical benefits olow-field MRI – including lower cost, wider bore, and longer T2* – with the clinical value of combined T2*-diffusion imaging to improve access and utility.
Authors
- Daniel C. Alexander (ORCID: https://orcid.org/0000-0003-2439-350X)
- Paddy J. Slator (ORCID: https://orcid.org/0000-0001-6967-989X)
- Jana Hutter (ORCID: https://orcid.org/0000-0003-3476-3500)
- Jordina Aviles Verdera (ORCID: https://orcid.org/0009-0007-7575-4244)
- Joseph V. Hajnal (ORCID: https://orcid.org/0000-0002-2690-5495)
- Raphaël Tomi‐Tricot (ORCID: https://orcid.org/0000-0002-6149-9154)
Institutions
- King's College London (GB)
- Siemens (United Kingdom) (GB)
- Siemens Healthcare (United States) (US)
- University College London (GB)
- Cardiff University (GB)
Publication Details
- Journal
- Placenta
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1016/j.placenta.2025.10.014
- Primary Topic
- MRI in cancer diagnosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- UK Research and Innovation
- National Institute for Health and Care Research
- University College London Hospitals NHS Foundation Trust
- National Institutes of Health
- Medical Research Council
- Engineering and Physical Sciences Research Council
- Centre For Medical Engineering, King’s College London